Agoracom Blog

CLIENT FEATURE: Robix (RZX: CSE) Revolutionary Patented Oil Spill Clean Up Technology

Posted by AGORACOM-JC at 2:43 PM on Thursday, December 18th, 2014

RZX: CSE

The Corporation is an “industrial products/technology” company, offering to investors a unique opportunity to participate in a leading company in the business of ownership of patents, and their development from commercialization to worldwide expansion through various business arrangements.

Highly Cost Effective – Clean Ocean Vessel

  • COV’s rapid recovery rate and large on-board storage result in low per barrel recovery cost.
  • COV’s simple design minimizes down time for repair and maintenance.
  • A two-man crew can be easily trained and the COV vessel can operate long hours without interruption
  • Selling COV products in the first half of 2015

Design Versatility

  • COV’S can be scaled to meet various application requirements (sizes range from 10 Ft., 20 Ft., 40 Ft., 80 Ft., 100 Ft. (references to length of vessel
  • A standard 40-foot COV is 40 feet in length, 26 feet in width, and 12 feet in depth
  • Recently completed the engineering drawings for the Clean Ocean Vessel (COV) and ordered critical components to initiate construction on the COV

Featured COV Technology

Recent Highlights

  • Signed an exclusive manufacturing agreement with Rayco Steel Ltd, to manufacture the Clean Ocean Vessel
  • Creating a new business division, through a subsidiary entity, to enter into the marine industry.
  • Announced that Rick Carson, of Montreal, PQ, has agreed to join Robix as a Strategic Advisor.
  • Announced that it intends to enter into an agreement with Rayco Steel Inc., wherein Rayco shall work on completion of engineering construction drawings for the anticipated construction of the first Clean Ocean Vessel.

How the COV compares to the competition:

  • Rates of oil recovered and recovery-throughput efficiencies are noted as “oil rate of recovery” (ORR) and “recovery efficiency” (RE).
  • The water surface lifting force generated by the COV’s patented contra-rotating drums acts in a suction or pumping manner that increases the ORR compared to conventional skimmer systems and the RE of the COV is in the 90-97% range. This is competitive with best in class 21st century technology in terms of ORR and RE.
  • Further improvements to the ORR (in terms of gallons per minute) could easily catapult the COV to “top three” status, by increasing the surface area of the drums through design modifications without impairing the stability of the vessel which is inherent to the COV design.
  • When our competitors’ skimmer systems meet waves above 18 inches, they are forced to suspend service. The COV operates in rough sea conditions (as high as 8 feet waves), significantly out-performing its competitors, and stands in a class of its own.

 

Hub On AGORACOM / Corporate Profile

 

INTERVIEW: Uragold Discusses Assay Results, Validated as Suitable for Silicon Metal and High Purity Quartz Applications

Posted by AGORACOM-JC at 11:32 AM on Wednesday, December 17th, 2014

UBR: TSX-V

Corrected SiO2 average for the 20 samples assayed is 99.65%, ranging from 99.37% to 99.86%. These results validate the fact that the Quartz material from the Roncevaux Property would make suitable feedstock for Silicon Metal production and applications requiring high purity quartz.

Uragold Bay Resources is a Gold and High Purity Quartz exploration junior focused on generating free cash flow from mining operations. The company’s business model is centered on developing mining projects suited for smaller-scale start-up, (Capex < C$10M), that will generate high yield returns (IRR > 50%).

Hub On AGORACOM / Read Release / Watch Interview

Lexaria Announces Name Change of PoViva Tea to ViPova(TM) Tea, and Provides Information on Hemp-Based Industry

Posted by AGORACOM-JC at 11:14 AM on Wednesday, December 17th, 2014

Kelowna, British Columbia–(December 17, 2014) – Lexaria, Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) announces that, effectively immediately, it’s 51%-owned company formerly known as PoViva Tea, will now operate with the trade name of ViPova™ Tea. Selling our products under the name of ViPova™ is a branding strategy undertaken to ensure long term protection of intellectual rights.

The name change does not affect ownership, operational or any other material issues. However the name change has delayed the product launch by 1-2 weeks, so that ViPova™ Tea is now expected to be available to be ordered by consumers around the first week of January.

Both Lexaria and ViPova™ also wish to clarify some important distinctions about the Cannabidiol(CBD)-from-hemp industry within which ViPova™ operates. Hemp based CBD is legal in all 50 states, as are hemp-based food products that can be purchased from national retailers like Whole Foods or Costco, and many regional food stores. Popular hemp food products include hemp cereal, seeds, milk, and oil.

Hemp based products contain very low thresholds of Tetrahydrocannabinol (THC) below government-imposed limits of less than 0.3%. At the same time, the CBD within hemp is NOT psychoactive and does not create feelings of euphoria. Hemp is grown legally in countries like Canada, England, New Zealand and parts of Europe, and is legally imported into the USA from these and other countries.

ViPova™ uses only legal CBD oil extracts, grown from legal hemp in nations where it is legal to do so, in ViPova™-branded tea. ViPova™ uses its patent-pending process to infuse concentrated amounts of CBD within lipids in its tea, providing more bioactivity and comfort to the body during the absorption process. Only ViPova™ has this ground-breaking technology for CBD/lipid infusion.

ViPova™ has not entered, and has no plans to enter, the medical marijuana market whether located within the USA or in any other country. ViPova™ is building a new company and product line focused exclusively on legal CBD products, which at this time are available only within the United States.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that any cannabinoid-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). ViPova™ products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

INTERVIEW: Stria Lithium Discusses Revolutionary Lithium Processing Technology

Posted by AGORACOM-JC at 10:06 AM on Wednesday, December 17th, 2014

SRA: TSX-V

WATCH INTERVIEW NOW!

  • Focused on the emerging green energy revolution, with a particular focus on Lithium.
  • Aiming to become one of the lowest cost producers in the world for battery- grade technology lithium through partnerships, licensing and joint ventures which are critical for high-technology green energy industries such as consumer electronics, energy storage and military.
  • Unveiled lithium procession technology that will provide the company with significant advantages.

Hub On AGORACOM / Corporate Website / Watch Interview Now!

Mazorro Provides Update on GrowPros MMP Activities

Posted by AGORACOM-JC at 8:36 AM on Wednesday, December 17th, 2014

OTTAWA, ONTARIO–(Dec. 17, 2014) - Mazorro Resources Inc. (the “Company“) (CSE:MZO)(FRANKFURT:JAM) announces that, further to its press release November 6, 2014 announcing the signature of a definitive agreement with GrowPros MMP Inc. (“GrowPros“) and in anticipation of a successful closing of the proposed amalgamation (“Amalgamation“), management of GrowPros has provided the following update on its activities.

GrowPros is finalizing the second revision to its application for a license under the Marihuana for Medical Purposes Regulations (“MMPR“). These revisions are part of the normal review process and GrowPros is impressed by the expediency with which its file has been reviewed by Health Canada. In addition, GrowPros will be closing the previously-announced transaction for the purchase of 190 acres of agricultural land located 45 minutes North of Ottawa, Ontario which will house a 50,000 sq. ft. production facility with unlimited room for expansion. As a result, management of GrowPros advises that it expects to receive a ready to build authorization from Health Canada in the second quarter of 2015.

GrowPros also reports that it is currently in preliminary negotiations with companies in various service and supply segments of the cannabis production industry. Management of GrowPros advises that merging main stream business into the cannabis industry will be a major focus of GrowPros going forward. Accordingly, these opportunities should provide a higher return on investment for GrowPros and, ultimately, a quicker route to profitability than solely being an applicant or licensed MMPR producer. This is in line with GrowPros‘ philosophy as a medical marihuana consultation and acquisition firm.

As previously announced on December 3, 2014, the Company would like to remind shareholders that the special meeting of the Company’s shareholders to approve the (i) proposed change of business from mineral resource exploration to the medical marijuana industry and (ii) change of name to “GrowPros Cannabis Inc. / Entreprise GrowPros cannabis inc.” will be held on December 29, 2014 (the “Special Meeting“). A notice of meeting, management information circular, and form of proxy in respect of the Special Meeting has been sent to shareholders and is available under the Company’s profile on the CSE website and on SEDAR.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to complete the Amalgamation and change of business, failure to obtain sufficient financing, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Any forward-looking statement speaks only as of the date on which it is made and except as may be required by applicable securities laws. The Company disclaims any intent or obligation to update any forward-looking statement.

Mazorro Resources Inc.
André Audet
Interim President, CEO, and CFO
(613) 241-2332

AGORACOM Small Cap TV “Best Of The Best” – 2014 Tax Loss Selling Stock Picking Contest

Posted by AGORACOM-JC at 7:16 PM on Tuesday, December 16th, 2014

Tax loss selling season is upon us once again and you know what that means … George vs Allan Stock Picking Contest!!  In this special episode of AGORACOM TV, George (Founder) and Allan (Chief Market Commentator) give their Top 5 Tax Loss Selling Candidates (+ 1 Bonus Pick) that are most likely to provide a pop to their portfolios by January 30, 2015.  There is a lot on the line in the wager between the two, with each providing completely different picks from the other and some great potential trades for viewers.

Last Year, Allan won the contest by a margin of 47.5% to 33.2% over a 40 day period.  Then, George struck back in the summer sell-off stock picking contest by a margin of  8.83% vs -34.66% … a thrashing J

However, George and Allan both agree the Tax Loss Selling contest is the Super Bowl of contests, so they have gone head to head again in a contest ending 45 days from now on January 30, 2015.  Click the video below to see their picks, listen to their reasons and even watch some chart action.

Want to catch up on previous shows?

Weekly “Best Of The Best” Summarizing The Best Picks From Our Daily Shows. Posted Every Friday Afternoon Watch Here

THIS WEEK’S SHOW SPONSORED BY THE FOLLOWING GREAT SMALL CAP COMPANY:


Quebec Quartz Assay Results Surpass Expectations, Validated as Suitable for Silicon Metal and High Purity Quartz Applications

Posted by AGORACOM-JC at 8:08 AM on Tuesday, December 16th, 2014

Montreal, Quebec / December 16, 2014, / Uragold Bay Resources Inc. (“Uragold”) (TSX Venture: UBR) is pleased to announce that it’s wholly owned subsidiary, Quebec Quartz, has received assay results for samples taken on the Roncevaux Quartz (Silica) property located in the Matapedia valley in the Gaspe region of Quebec.

The corrected SiO2 average for the 20 samples assayed is 99.65%, ranging from 99.37% to 99.86%. These results validate the fact that the Quartz material from the Roncevaux Property would make suitable feedstock for Silicon Metal production and applications requiring high purity quartz.

Patrick Levasseur, President and COO of Uragold stated, “We are extremely happy with these results, they have surpassed our initial expectations and validated our decision to focus on our Ronceveaux property since it is situated within 80 kilometers from a deep-sea harbour that can handle bulk shipments for worldwide exports, less then 300 Km from the future FerroAtlantica Port Cartier Silicon Metal production facilities and less then 500 Km Globe Specialty Metals Becancour silicon metal production facilities.”

In 2003, an exploration potential of ? 400,000 tons of SiO2 was calculated using the 360 m surface length of the Quartz vein, its average width (between 3 m and 12m) and assuming a continuation up to 50 M of depth. (GM60610: Barrette, Jean-Paul. 2003. Rapport des travaux d’exploration miniere sur la veine de quartz pur. Projet Silice Roncevaux, Canton Roncevaux, Gaspesie).

IMPORTANCE OF QUARTZ (SILICA)

Quartz (SiO2) is one of the most abundant minerals. It occurs in many different settings throughout the geological record. However, high Purity Quartz deposits with low impurities are rare and only a few deposits are suitable in volume, quality and amenability to be tailored to refining methods for specialty high purity applications.

High Purity Quartz (HPQ), and Silicon Metal is used in large part in the aluminum industry while Ultra High Purity Quartz (UHPQ) has become one of today’s key strategic minerals with applications in high-tech industries that include semiconductors, LCD displays, fused quartz tubing, microelectronics, solar silicon applications and recently, Silicon Anode Lithium Batteries.

GO FORWARD PLAN:

The Corporation intends to advance the development of the Roncevaux project by completing the following steps during Q1 & Q2 2015:

  1. 1.Send material to specialized laboratories to find the best beneficiation process to transform the Roncevaux Quartz material into Ultra High Purity Quartz for advanced material and pharmaceutical applications.

High Purity Quartz beneficiated to 99.998% Si02 can command prices up to
US$ 6,000/T (Source: Dorfner Anzaplan). The Corporation intends to focus its interest on this segment of the market.

Quartz for Silicon Metal the sales price averages between US$ 100/T to US$ 250/T.

  1. 2.Send quartz samples to Silicon Metals and other material buyers.

Multiple end-users have approached the Corporation. Having now received our own lab results, the Corporation is ready to start direct discussion with interested parties.

  1. 3.Evaluating the Property Potential.

The exact volume of the quart vein systems found on the Roncevaux Property needs to be confirmed and measured; and quartz occurrences contained in the new claims staked by Quebec Quartz after the first work programme need to be explored.

Mr. Levasseur added, “2015 will be an exciting year as we continue to develop Quebec Quartz’s exciting high purity silica projects while developing two gold mines in the Beauce region of Quebec.”

PARTIAL TABLE OF RESULTS:

Report Number: A14-09140
Analyte Symbol SiO2 Al2O3 Fe2O3(T) LOI Total SiO2
Unit Symbol % % % % % Corrected
Detection Limit 0.01 0.01 0.01 0.01 for lost
Analysis Method FUS-XRF FUS-XRF FUS-XRF FUS-XRF FUS-XRF Carbonate
41962 98.46 0.02 0.02 0.12 98.64 99.82%
41962-B 98.67 0.15 0.03 0.12 99.00 99.67%
41963 98.59 0.07 0.02 0.18 98.88 99.71%
41963-B 98.57 0.17 0.03 0.28 99.11 99.46%
41964 99.37 0.25 0.02 0.19 99.88 99.49%
41964-B 98.76 < 0.01 0.01 0.15 98.95 99.81%
41965 98.99 0.16 0.01 0.15 99.34 99.65%
41965-B 98.82 0.13 0.02 0.18 99.18 99.64%
41966 99.85 0.10 0.03 0.17 100.20 99.65%
41966-B 99.07 0.04 0.01 0.22 99.37 99.70%
41967 98.47 0.04 0.01 0.16 98.70 99.77%
41967-B 99.32 0.29 0.08 0.17 99.92 99.40%
41968 100.23 0.08 0.01 0.17 100.50 99.73%
41968-B 99.92 0.17 0.04 0.16 100.30 99.62%
41969 98.72 0.25 0.02 0.22 99.31 99.41%
41969-B 98.00 0.26 0.05 0.23 98.62 99.37%
41970 100.16 < 0.01 0.01 0.16 100.30 99.86%
41970-B 100.38 < 0.01 0.02 0.16 100.60 99.78%
41971 99.96 0.03 0.01 0.15 100.20 99.76%
41971-B 99.87 < 0.01 0.02 0.14 100.10 99.77%
Average 99.21 0.14 0.02 0.17 99.56 99.65%

The average losses in ignition (“LOI”) (material and moisture burned off during the assays) for the 20 samples is 0.17% (ranging between 0.12% and 0.23%) this suggest that a certain percentage of the alkali metals are present as a carbonate molecule, and with an average laboratory total of 99.55% (ranging between 98.88 % and 100.6%), a correction for the lost of carbonate is required in order to present the actual SiO2 grade of the samples.

Assay results confirm that the material is low to very low in all the major contaminants: Al2O3 average: 0.14%, range from <0.01% to 0.29%, Fe2O3 average: 0.02%, range from 0.01% to 0.08%, Co3O4 all samples <0.005%, CuO all samples <0.005%, MnO all samples <0.001%, NiO 15 samples <0.003%, the rest ranging from 0.003% to 0.012%, MgO all samples <0.01%, CaO 18 samples <0.01%, Na2O all samples <0.01%, K2O 8 samples <0.01%, the rest ranging from 0.01% to 0.03%, TiO2 9 samples <0.01%, the rest 0.01%, P2O5 average: 0.02%, range from 0.01% to 0.04%, Cr2O3 all samples <0.01%, V2O5 all samples <0.003%.

The samples were taken over the historical quartz vein from parallel trenches along a 360 m long quartz vein that varied between 3 m and 12 m in width. Samples weighing approximately 10 kg each along with a 3 kg duplicate were bagged on site. Ten samples were taken from each site and the field crew brought back approximately 130 kg.

The material was first sent to the INRS (Institut National de la Recherche Scientifique) laboratory in Quebec City to be prepared for testing for High Purity Silica and Silicon Metal potential. 20 prepared samples (an original and a duplicate) were sent to the Activation Laboratories in Ancaster, Ontario for whole rock and trace elements (FUS X-Ray Fluorescence (“XRF”)) assay.


Click Image To View Full Size

Picture 1: Field sample from the Roncevaux Property, Sample # 41765 tested 99.65% SiO2


Click Image To View Full Size

Picture 2: Visible showing of the Quartz veins on the Roncevaux Property.

Mr. Robert Gagnon, P. Geo, is a Qualified Person as defined by National Instrument 43-101, supervised the preparation of the information in this news release.

All the information on exploration potential herewithin presented is historical in nature and while relevant, the information was obtained before the implementation of National Instrument 43-101 and as such does not meet National Instrument 43-101 reporting standards. The historical estimate should not be relied upon until the Company can confirm them.

About Quebec Quartz

Uragold 100 % wholly owned subsidiary, Quebec Quartz, by virtue of being a first mover into this market, succeeded in becoming the largest holder of distinct High Purity Quartz properties in Quebec. Quebec Quartz strategic portfolio of High Purity Quartz (+99.+% SiO2) deposits and closed silicon metal mines in Quebec represent a unique and valuable asset. Quebec’s Quartz aims to become a leading supplier of Ultra High Purity Quartz

About Uragold Bay Resources Inc.

Uragold Bay Resources is a TSX-V listed Gold and High Purity Quartz exploration junior focused on generating free cash flow from mining operations. Our business model is centered on developing mining projects suited for smaller-scale start-up, (Capex < C$10M), that will generate high yield returns (IRR > 50%). Uragold will reach these goals by developing Quebec’s first placer mine in 50 years, the Beauce Placer Project developing and, in partnership with Golden Hope Mines, the Bellechasse-Timmins Gold Deposit.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman and CEO
Patrick Levasseur, President and COO

Tel: (514) 846-3271

www.uragold.com

Supreme Pharmaceuticals Completes Upgrades on Marijuana Greenhouse Facility and Awaits Pre-License Inspection by Health Canada – Video News Alert on InvestmentPitch.com

Posted by AGORACOM-JC at 11:08 AM on Monday, December 15th, 2014

Vancouver, British Columbia–(December 15, 2014) – Supreme Pharmaceuticals (CSE:SL) (OTC PINK: SPRWF), announced the completion of security and infrastructure upgrades at its hybrid greenhouse facility located in southern Ontario, and awaits pre-license inspection by Health Canada. The 342,000 square foot greenhouse, purchased in May 2014, is located in Kincardine.

InvestmentPitch.com has produced a “video news alert” which provides a brief overview of the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter “Supreme” in the search box.

The company has spent approximately $4 million in upgrades to transform the out-of-use tomato greenhouse into a highly secured, state-of-the-art, automated marijuana facility. These upgrades include a level 9 security vault capable of storing up to $150 million of dried marijuana, a sophisticated digital security system including intrusion detection and visual surveillance, along with sanitation and automation systems, all of which have been designed and installed to meet or exceed regulatory requirements set by Health Canada.

The company and its management team have carefully planned the upgrades to provide an optimal environment to manufacture high quality, low-cost medical marijuana. If successful in obtaining the license to produce medical marijuana subsequent to the pre-license inspection, the company expects to immediately commence growing in its first completed phase of the Facility. Subsequent phases of the facility are expected to be built out later in 2015 which will increase the productive capacity of the facility.

John Fowler, Director of Operations, stated: “The construction thus far has been a massive undertaking for us. We are excited to move forward in the licensing process and stay on track with our goal of providing high-quality, low-cost medical marijuana in the coming months.”

The company recently closed the second tranche of its private placement, placing a total of 5.6 million units at $0.32 for gross proceeds of $1.8 million. Each unit consisted of one share and ½ a warrant, with each warrant exercisable at $0.50 for 2 years. Management believes this funding will take the company through the licensing stage and beyond.

In November, the company announced changes and additions to the management team, which it considered were the final pieces to ensure Supreme’s future success as a leader in the medical marijuana industry.

The shares are currently trading at $0.38, and with 76.2 million shares outstanding, the company is capitalized at $29 million. For more information, please visit the company’s website, www.supreme.ca, call 604-674-2191 or email info@supreme.ca.

About InvestmentPitch

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases and research reports.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
bmorgan@investmentpitch.com

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Lexaria Closes 51% Acquisition of PoViva Tea, LLC

Posted by AGORACOM-JC at 4:39 PM on Friday, December 12th, 2014

Kelowna, British Columbia–(December 12, 2014) – Lexaria, Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) is pleased to announce it has closed the 51% acquisition of Poviva Tea, LLC.

As the final part of the closing, Lexaria has issued 119,047 restricted common shares of the Company to each of the two founders of PoViva Tea, LLC.

All issued shares will be subject to a hold period, for any resale into the USA under Rule 144, of six months and one day. The share issuance is subject to normal regulatory approvals. The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that and cannabidiol-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). PoViva products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Supreme Completes Pre-License Upgrades at Kincardine Greenhouse

Posted by AGORACOM-JC at 9:22 AM on Friday, December 12th, 2014

VANCOUVER, BRITISH COLUMBIA–(Dec. 12, 2014) - Supreme Pharmaceuticals Inc. (the “Company”) (OTCBB:SPRWF) (CSE:SL) is pleased to report that the Company has completed the security and infrastructure upgrades at the hybrid industrial greenhouse facility in Kincardine, Ontario (the “Facility“) and is ready for the Health Canada pre-license inspection of the Facility.

Since the acquisition of the 342,000 sq. ft. facility in May 2014, the Company has spent approximately $4M in upgrades to transform the Facility from an out-of use tomato greenhouse to a highly secured, state-of-the-art, automated medical marijuana facility. These upgrades include a level 9 security vault capable of storing up to $150 million of dried marijuana, a sophisticated digital security system including intrusion detection and visual surveillance, as well as sanitation and automation, all which meets or exceeds the regulatory requirements set by Health Canada.

The Company and its management team have carefully planned the upgrades of the Facility to provide an optimal environment to manufacture high quality, low-cost medical marijuana. If successful in obtaining the license to produce medical marijuana subsequent to the pre-license inspection, the Company expects to immediately commence growing in its first completed phase of the Facility. Subsequent phases of the Facility are expected to be built out later in 2015 which will increase the productive capacity of the Facility. No date has been set yet for the Health Canada inspection.

John Fowler, the Company’s Director of Operations, stated: “The construction thus far has been a massive undertaking for us. We are excited to move forward in the licensing process and stay on track with our goal of providing high-quality, low-cost medical marijuana in the coming months.”

FORWARD-LOOKING INFORMATION

This news release contains forwardlooking statements and forwardlooking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forwardlooking statements or information. More particularly and without limitation, this news release contains forwardlooking statements and information relating to the obtaining of a grow license, as well as the Company’s corporate strategy. The forwardlooking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan following the issuance of the required licenses by Health Canada. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forwardlooking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forwardlooking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and related regulations. Accordingly, readers should not place undue reliance on the forwardlooking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forwardlooking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forwardlooking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

Supreme Pharmaceuticals Inc.
Investor Relations
430 – 580 Hornby Street, Vancouver BC, V6C 3B6
(604) 674-2191
info@supreme.ca
www.supreme.ca